The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy
- PMID: 19150546
- DOI: 10.1016/j.juro.2008.10.163
The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy
Abstract
Purpose: We evaluated the association between the number of biopsy cores revealing high grade prostatic intraepithelial neoplasia and prostate cancer in an era of extended biopsy protocol.
Materials and methods: From December 2004 to September 2007 patients referred to our clinic with a prostate specific antigen of 4 ng/ml or greater or an abnormal digital rectal examination were scheduled for transrectal ultrasound prostatic biopsy with a 12-core template. In patients with high grade prostatic intraepithelial neoplasia we proposed a second prostate specific antigen evaluation and a new 12-core biopsy after 6 months independent of prostate specific antigen. Nonparametric tests were applied for statistical analysis.
Results: We evaluated 650 patients. Of the 147 patients (22%) with high grade prostatic intraepithelial neoplasia 117 underwent a second biopsy 6 months later. Patient characteristics (age, prostate specific antigen, free-to-total prostate specific antigen ratio, prostate volume, prostate specific antigen density) were similar at initial and repeat biopsy. On second biopsy 22 patients (18.8%) presented with prostate cancer (14 with Gleason score 6, 7 with Gleason score 7 and 1 with a Gleason score 8), 75 showed isolated high grade prostatic intraepithelial neoplasia (64.2%) and 20 (17%) had chronic prostatitis. The number of cores (4 or more) involved with high grade prostatic intraepithelial neoplasia on the first biopsy was significantly associated with prostate cancer on the second biopsy (p = 0.001). Prostate specific antigen could not be used to distinguish prostate cancer from benign disease or high grade prostatic intraepithelial neoplasia.
Conclusions: The number of cores with high grade prostatic intraepithelial neoplasia seems to be associated with the presence of cancer on second biopsy. A 6-month biopsy is recommended in patients with high grade prostatic intraepithelial neoplasia when 4 or more cores with high grade prostatic intraepithelial neoplasia are detected in the initial biopsy sample independent of prostate specific antigen.
Comment in
-
Re: The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy: C. De Nunzio, A. Trucchi, R. Miano, A. Stoppacciaro, H. Fattahi, A. Cicione and A. Tubaro J Urol 2009; 181: 1069-1075.J Urol. 2009 Oct;182(4):1653; author reply 1653-4. doi: 10.1016/j.juro.2009.06.061. Epub 2009 Aug 15. J Urol. 2009. PMID: 19683763 No abstract available.
-
Words of wisdom. Re: The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.Eur Urol. 2009 Dec;56(6):1086. doi: 10.1016/j.eururo.2009.09.007. Eur Urol. 2009. PMID: 20965037 No abstract available.
Similar articles
-
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.J Urol. 2010 Nov;184(5):1958-62. doi: 10.1016/j.juro.2010.06.137. Epub 2010 Sep 17. J Urol. 2010. PMID: 20846692
-
Is race a positive predictor of cancer on repeat prostate biopsy?J Urol. 2006 Sep;176(3):1114-7. doi: 10.1016/j.juro.2006.04.041. J Urol. 2006. PMID: 16890704
-
The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.BJU Int. 2007 Apr;99(4):770-4. doi: 10.1111/j.1464-410X.2006.06728.x. Epub 2007 Jan 16. BJU Int. 2007. PMID: 17233800
-
Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.J Urol. 2001 Sep;166(3):866-70. J Urol. 2001. PMID: 11490235 Review.
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
Cited by
-
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study.BMC Cancer. 2016 Feb 4;16:59. doi: 10.1186/s12885-016-2085-8. BMC Cancer. 2016. PMID: 26846521 Free PMC article.
-
The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.Int Urol Nephrol. 2016 Dec;48(12):2015-2021. doi: 10.1007/s11255-016-1407-8. Epub 2016 Aug 31. Int Urol Nephrol. 2016. PMID: 27580731
-
Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram.Metabolites. 2023 Jan 9;13(1):111. doi: 10.3390/metabo13010111. Metabolites. 2023. PMID: 36677036 Free PMC article.
-
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis.Prostate Cancer Prostatic Dis. 2016 Mar;19(1):35-9. doi: 10.1038/pcan.2015.45. Epub 2015 Oct 6. Prostate Cancer Prostatic Dis. 2016. PMID: 26439746
-
The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.World J Urol. 2014 Apr;32(2):323-8. doi: 10.1007/s00345-012-0919-9. Epub 2012 Jul 31. World J Urol. 2014. PMID: 22847453
MeSH terms
LinkOut - more resources
Full Text Sources
Medical